LifeStance Health GroupLFST +2.22%57 PE Ratio (TTM) is 160.83 as of Jun. 25, 2026, which is 32% below its 10-year median of 236.67. GuruFocus rates LFST with a GF Score™ of 57/100 and a GF Value™ of $8.22 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 431 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 93.27% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-25), LifeStance Health Group's share price is
$9.65.
LifeStance Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06. Therefore, LifeStance Health Group's PE Ratio (TTM) for today is 160.83.
The historical rank and industry rank for LifeStance Health Group's PE Ratio (TTM) or its related term are showing as below:
LFST'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 105.17 Med: 236.67 Max: 370
Current: 160.83
During the past 7 years, the highest PE Ratio (TTM) of LifeStance Health Group was 370.00. The lowest was 105.17. And the median was 236.67.
LFST's PE Ratio (TTM) is ranked worse than 93.27% of 431
companies
in the Healthcare Providers & Services industry
Industry Median: 21.32
vs LFST: 160.83
During the past 7 years, LifeStance Health Group's highest 3-Year average EPS without NRI Growth Rate was 47.20% per year. The lowest was 47.20% per year. And the median was 47.20% per year.
LifeStance Health Group (NAS:LFST) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
LifeStance Health Group PE Ratio (TTM) Related Terms
LifeStance Health Group PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LifeStance Health Group's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group PE Ratio (TTM) vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's PE Ratio (TTM) falls into.
LifeStance Health Group PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
LifeStance Health Group's Share Price of today is $9.65.
LifeStance Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
LifeStance Health Group (LFST) has a PE Ratio (TTM) of 160.83 as of Jun. 25, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on LifeStance Health Group and its competitors. This is 32% below median its historical median of 236.67. Over the past decade, LifeStance Health Group's PE Ratio (TTM) has ranged from 105.17 to 370.00. According to the industry distribution chart, LifeStance Health Group ranks #402 out of 431 companies in the Healthcare Providers & Services industry, placing it in the top 93.3%.
Is LifeStance Health Group's PE Ratio (TTM) too high?
LifeStance Health Group's current PE Ratio (TTM) of 160.83 is 32% below median its 10-year median of 236.67. Over the past 10 years, this metric has ranged from a low of 105.17 to a high of 370.00. The Healthcare Providers & Services industry median PE Ratio (TTM) is 21.32. LifeStance Health Group's value of 160.83 is 654.4% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #402 out of 431 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeStance Health Group has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's PE Ratio (TTM) compare to NHC and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #402 out of 431 companies for PE Ratio (TTM). This places LifeStance Health Group in the lower half of its industry. The industry median PE Ratio (TTM) is 21.32. LifeStance Health Group's value of 160.83 is 654.4% above this benchmark. Historically, LifeStance Health Group's own PE Ratio (TTM) has ranged from 105.17 to 370.00 over the past decade. While the company's 10-year median is 236.67 vs. the industry median of 21.32, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Healthcare Providers & Services company?
The median PE Ratio (TTM) among Healthcare Providers & Services companies is 21.32, based on 431 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current PE Ratio (TTM) of 160.83 is 654.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio (TTM) is 21.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current PE Ratio (TTM) is 160.83, which is 32% below median its own 10-year median of 236.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.22, compared to a current price of $9.65 — trading 17.4% above its estimated fair value. The current PE Ratio (TTM) is 160.83, which is 32% below median its 10-year median of 236.67 and 654.4% above the Healthcare Providers & Services industry median of 21.32. LifeStance Health Group's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current PE Ratio (TTM) is 160.83 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $9.65 is trading 17.4% above its estimated GF Value™ of $8.22.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
PE Ratio (TTM): 160.83 (32% below median its 10-year median of 236.67)
GF Value™: $8.22 vs. price of $9.65 (17.4% above fair value)
Industry Position: 654.4% above the Healthcare Providers & Services median (#402 of 431)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
57GF Score
Get the complete analysis for LFST
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
